Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://hassanljvw808749.ttblogs.com/18853792/retaglutide-a-promising-glp-1-receptor-agonist